Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

86
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

25
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

28
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.9K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
563
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

884
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
884

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Domperidone for Patients With Symptoms of Gastroparesis; Long-Term Results.

Neurogastroenterology and motility·2026
Same author

Unusual Instance of Primary Diffuse Large B-cell Lymphoma of the Colon.

Cureus·2023
Same author

Characteristics and outcomes of patients with gastroparesis using enteral and/or exclusive parenteral nutrition.

JPEN. Journal of parenteral and enteral nutrition·2023
Same author

Association Between Helicobacter pylori and Steatosis Severity on Transient Elastography.

Cureus·2023
Same author

Esophageal Perforation after Using a Single-Use Disposable Duodenoscope.

Case reports in gastroenterology·2022
Same author

Impact of patient position on esophageal motility disorders using high-resolution esophageal manometry with impedance (HREMI): supine versus upright swallows.

Esophagus : official journal of the Japan Esophageal Society·2021

Related Experiment Video

Updated: Apr 30, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
10:45

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

14.7K

Alcoholic hepatitis: current management.

Erin K J Spengler1, Jeffrey Dunkelberg, Ron Schey

  • 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA, 52242-1081, USA, erin-spengler@uiowa.edu.

Digestive Diseases and Sciences
|May 7, 2014
PubMed
Summary
This summary is machine-generated.

Severe alcoholic hepatitis treatment involves corticosteroids or pentoxifylline for mortality benefit. N-acetylcysteine may reduce short-term mortality and complications, while nutritional support is crucial. Liver transplantation is a future consideration for select patients.

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

7.2K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.5K

Related Experiment Videos

Last Updated: Apr 30, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
10:45

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

14.7K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

7.2K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.5K

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Background:

  • Alcoholic hepatitis is a severe form of alcoholic liver disease.
  • It carries a high mortality rate, especially in severe cases (40-50%).
  • Patients typically present with symptoms like jaundice, fever, and ascites after prolonged alcohol abuse.

Purpose of the Study:

  • To review current treatment strategies for alcoholic hepatitis.
  • To evaluate the efficacy of different therapeutic interventions.
  • To discuss the role of nutritional support and potential future treatments like liver transplantation.

Main Methods:

  • Review of existing literature on alcoholic hepatitis treatment.
  • Analysis of data regarding the effectiveness of corticosteroids, pentoxifylline, and N-acetylcysteine.
  • Assessment of nutritional support recommendations and liver transplantation indications.

Main Results:

  • Corticosteroids or pentoxifylline significantly reduce mortality in severe alcoholic hepatitis (Maddrey's score >32).
  • N-acetylcysteine, when added to corticosteroids, decreases hepatorenal syndrome, infection, and short-term mortality, but not 6-month mortality.
  • High-calorie, high-protein nutritional support is recommended for malnourished patients.

Conclusions:

  • Current treatments offer mortality benefits for severe alcoholic hepatitis.
  • N-acetylcysteine provides additional short-term benefits, but long-term impact is limited.
  • Nutritional support is essential, and liver transplantation remains an option for highly selected patients in the future.